Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Cancer Biomarkers : Section a of Disease Markers|February 12, 2013
CD133 is a predictor of poor survival in head and neck squamous cell carcinomasMartin Canis, Axel Lechner, Brigitte Mack, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 15, 2012
CD133 induces tumour-initiating properties in HEK293 cellsMartin Canis, Axel Lechner, Brigitte Mack, et al.Biochemical and Biophysical Research Communications|September 8, 2004
Allogenic antibody-mediated identification of head and neck cancer antigensJens Rauch, Martin Ahlemann, Martina Schaffrik, et al.Cancer Letters|April 15, 2003
Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomasChristof Pauli, Markus Münz, Cuong Kieu, et al.Journal of Biophotonics|January 21, 2017
Confocal laser endomicroscopy in head and neck malignancies using FITC-labelled EpCAM- and EGF-R-antibodies in cell lines and tumor biopsiesAnna S Englhard, Alexander Palaras, Veronika Volgger, et al.Stem Cells (Dayton, Ohio)|May 1, 2013
CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasisMaximilian Gassenmaier, Dong Chen, Alexander Buchner, et al.Anticancer Research|October 4, 2011
Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID miceMichaela Andratschke, Christian W Luebbers, Veronika Johannson, et al.Cancer Research|October 16, 2003
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancerEvelyn Hartmann, Barbara Wollenberg, Simon Rothenfusser, et al.Clinical and Vaccine Immunology : CVI|August 25, 2006
Analysis of plasmacytoid and myeloid dendritic cells in nasal epitheliumEvelyn Hartmann, Hendrik Graefe, Anne Hopert, et al.Cancer Immunology, Immunotherapy : CII|March 28, 2007
Immune restoration in head and neck cancer patients after in vivo COX-2 inhibitionStephan Lang, Sanjay Tiwari, Michaela Andratschke, et al.Pageof 5